Genomic Biomarker Global Market Report 2025

Global Genomic Biomarker Market Report 2025

Genomic Biomarker Global Market Report 2025 – By Type (Predictive Biomarkers, Prognostic Biomarkers), By Disease Indication (Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications), By Validation (Analytical Validation, Clinical Validation, Clinical Utility), By End-User (Hospitals, Diagnostic Centers, Research Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Genomic Biomarker Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Genomic Biomarker Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Genomic Biomarker Global Market Report 2025

Proud Members Of

What Is Covered Under Genomic Biomarker Market?

A genomic biomarker is a specific genetic sequence or molecular characteristic found in an individual's genome that can assess disease risk, predict disease progression, or determine response to a particular treatment. These biomarkers are often used in personalized medicine to tailor treatments based on an individual's genetic profile.

The main types of genomic biomarkers are predictive biomarkers and prognostic biomarkers. Predictive biomarkers are biological markers used to identify how likely a patient is to respond to a specific treatment or drug. It is used for various diseases such as oncology, cardiovascular diseases, neurological diseases, renal disorders, and others, and it provides analytical validation, clinical validation, and clinical utility. It is used by various end users, including hospitals, diagnostic centers, research laboratories, and others.

What Is The Genomic Biomarker Market Size 2025 And Growth Rate?

The genomic biomarker market size has grown rapidly in recent years. It will grow from $8.4 billion in 2024 to $9.9 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to growth in awareness of genetic disorders, rise in demand for targeted therapies, increasing utilization of big data in genomics, growth in global genomic databases, and rise in number of biomarker-based clinical trials.

What Is The Genomic Biomarker Market Growth Forecast?

The genomic biomarker market size is expected to see rapid growth in the next few years. It will grow to $18.93 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to growing focus on the availability of personalized medications, rising occurrences of cardiovascular diseases, rising number of patients with neurological diseases, growing investments in genomic research, and growing adoption of personalized nutrition. Major trends in the forecast period include technological advancements, digital health, artificial intelligence, machine learning, and personalized medicine.

Genomic Biomarker Market Size and growth rate 2025 to 2029: Graph

How Is The Genomic Biomarker Market Segmented?

The genomic biomarker market covered in this report is segmented –

1) By Type: Predictive Biomarkers, Prognostic Biomarkers

2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications

3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility

4) By End-User: Hospitals, Diagnostic Centers, Research Laboratories, Other End Users

Subsegments:

1) By Predictive Biomarkers: Genetic Biomarkers For Disease Susceptibility, Pharmacogenomic Biomarkers For Drug Response, Early Detection Biomarkers For Disease Prediction, Biomarkers For Treatment Response Prediction

2) By Prognostic Biomarkers: Biomarkers For Disease Progression, Biomarkers For Outcome Prediction, Survival And Recurrence Biomarkers, Biomarkers For Treatment Efficacy And Prognosis

Book your 30 minutes free consultation with our research experts

What Is Driving The Genomic Biomarker Market? Impact of Chronic Disease Prevalence on Genomic Biomarker Market Growth

The increasing prevalence of chronic diseases is expected to propel the growth of the genomic biomarker market going forward. Chronic diseases are long-lasting health conditions that persist over time and often progress slowly. The increasing prevalence of chronic diseases is due to aging populations and rising rates of lifestyle-related conditions such as obesity and diabetes. Genomic biomarkers enable early detection and personalized prevention strategies for chronic diseases by identifying genetic predispositions and tailoring interventions. This proactive approach helps reduce prevalence by targeting at-risk individuals before disease onset. For instance, in September 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, each year, there are 41 million deaths worldwide, accounting for 74% of all fatalities attributed to chronic diseases. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, the increasing prevalence of chronic diseases drives the growth of genomic biomarkers.

Who Are The Major Players In The Global Genomic Biomarker Market?

Major companies operating in the genomic biomarker market are Pfizer Inc., Roche Diagnostics, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Foundation Medicine Inc., QIAGEN N.V., Almac Group Ltd., Myriad Genetics Inc., Invitae Inc., Guardant Health Inc., Novogene Inc., Twist Bioscience Corp., NanoString Technologies Inc., Quanterix Corp., Personalis Inc., GENEWIZ Inc., Agena Bioscience Inc., Creative Diagnostics Ltd., OncoDNA SA, Genome Life Sciences Ltd., Epigenomics AG.

What Are The Key Trends Of The Global Genomic Biomarker Market? Technological Advances In Genomic Biomarkers

Major companies operating in the genomic biomarker market are focusing on developing advanced products, such as advanced liquid biopsy assays, to enable comprehensive genomic profiling of solid tumors. A liquid biopsy assay is a diagnostic test that analyzes genetic material, typically circulating tumor DNA (ctDNA), from a blood sample to detect and monitor cancer. Identifying genomic biomarkers can provide information about specific mutations, gene expression profiles, or other genetic alterations associated with cancer. For instance, in November 2023, Illumina Inc., a US-based biotechnology company, launched an advanced liquid biopsy assay, the TruSight Oncology 500 ctDNA v2 (TSO 500 ctDNA v2), for comprehensive genomic profiling of solid tumors. The assay offers enhanced analytical sensitivity by detecting low-frequency variants with just 20 ng of cell-free DNA, down from 30 ng. It delivers results in under four days, greatly accelerating genomic profiling compared to traditional methods. The streamlined workflow and forthcoming automation will simplify lab integration and boost efficiency.

What Are Latest Mergers And Acquisitions In The Genomic Biomarker Market? Biocare Medical Acquires Empire Genomics To Strengthen Molecular Diagnostics And Expand Cancer Research Tools

In November 2022, Biocare Medical LLC, a US-based immunohistochemistry and FISH instrumentation and reagents provider acquired Empire Genomics for an undisclosed amount. With this acquisition, Biocare Medical LLC aims to significantly enhance its molecular diagnostics capabilities and expand its portfolio of cancer research tools. Empire Genomics is a US-based cancer molecular diagnostics company that provides genomic biomarkers.

What Is The Regional Outlook For The Global Genomic Biomarker Market?

North America was the largest region in the genomic biomarker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genomic biomarker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genomic Biomarker Market?

The genomic biomarker market consists of sales of genetic testing kits, genotyping arrays, pharmacogenomic panels and cancer genomics panels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Genomic Biomarker Industry?

The genomic biomarker market research report is one of a series of new reports from The Business Research Company that provides genomic biomarker market statistics, including genomic biomarker industry global market size, regional shares, competitors with a genomic biomarker market share, detailed genomic biomarker market segments, market trends and opportunities, and any further data you may need to thrive in the genomic biomarker industry. This genomic biomarker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Genomic Biomarker Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	9.9 billion
Revenue Forecast In 2034	$18.93 billion
Growth Rate	CAGR of 17.6% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The genomic biomarker market covered in this report is segmented – 1) By Type: Predictive Biomarkers, Prognostic Biomarkers 2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications 3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility 4) By End-User: Hospitals, Diagnostic Centers, Research Laboratories, Other End Users Subsegments: 1) By Predictive Biomarkers: Genetic Biomarkers For Disease Susceptibility, Pharmacogenomic Biomarkers For Drug Response, Early Detection Biomarkers For Disease Prediction, Biomarkers For Treatment Response Prediction 2) By Prognostic Biomarkers: Biomarkers For Disease Progression, Biomarkers For Outcome Prediction, Survival And Recurrence Biomarkers, Biomarkers For Treatment Efficacy And Prognosis
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Roche Diagnostics, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Foundation Medicine Inc., QIAGEN N.V., Almac Group Ltd., Myriad Genetics Inc., Invitae Inc., Guardant Health Inc., Novogene Inc., Twist Bioscience Corp., NanoString Technologies Inc., Quanterix Corp., Personalis Inc., GENEWIZ Inc., Agena Bioscience Inc., Creative Diagnostics Ltd., OncoDNA SA, Genome Life Sciences Ltd., Epigenomics AG.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Genomic Biomarker Market Characteristics

3. Genomic Biomarker Market Trends And Strategies

4. Genomic Biomarker Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Genomic Biomarker Growth Analysis And Strategic Analysis Framework

5.1. Global Genomic Biomarker PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Genomic Biomarker Market Growth Rate Analysis

5.4. Global Genomic Biomarker Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Genomic Biomarker Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Genomic Biomarker Total Addressable Market (TAM)

6. Genomic Biomarker Market Segmentation

6.1. Global Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Predictive Biomarkers

Prognostic Biomarkers

6.2. Global Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Cardiovascular Diseases

Neurological Diseases

Renal Disorders

Other Disease Indications

6.3. Global Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Analytical Validation

Clinical Validation

Clinical Utility

6.4. Global Genomic Biomarker Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Centers

Other End-User

6.5. Global Genomic Biomarker Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genetic Biomarkers For Disease Susceptibility

Pharmacogenomic Biomarkers For Drug Response

Early Detection Biomarkers For Disease Prediction

Biomarkers For Treatment Response Prediction

6.6. Global Genomic Biomarker Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biomarkers For Disease Progression

Biomarkers For Outcome Prediction

Survival And Recurrence Biomarkers

Biomarkers For Treatment Efficacy And Prognosis

7. Genomic Biomarker Market Regional And Country Analysis

7.1. Global Genomic Biomarker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Genomic Biomarker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomic Biomarker Market

8.1. Asia-Pacific Genomic Biomarker Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomic Biomarker Market

9.1. China Genomic Biomarker Market Overview

9.2. China Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomic Biomarker Market

10.1. India Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomic Biomarker Market

11.1. Japan Genomic Biomarker Market Overview

11.2. Japan Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomic Biomarker Market

12.1. Australia Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomic Biomarker Market

13.1. Indonesia Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomic Biomarker Market

14.1. South Korea Genomic Biomarker Market Overview

14.2. South Korea Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomic Biomarker Market

15.1. Western Europe Genomic Biomarker Market Overview

15.2. Western Europe Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomic Biomarker Market

16.1. UK Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomic Biomarker Market

17.1. Germany Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomic Biomarker Market

18.1. France Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomic Biomarker Market

19.1. Italy Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomic Biomarker Market

20.1. Spain Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomic Biomarker Market

21.1. Eastern Europe Genomic Biomarker Market Overview

21.2. Eastern Europe Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomic Biomarker Market

22.1. Russia Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomic Biomarker Market

23.1. North America Genomic Biomarker Market Overview

23.2. North America Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomic Biomarker Market

24.1. USA Genomic Biomarker Market Overview

24.2. USA Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomic Biomarker Market

25.1. Canada Genomic Biomarker Market Overview

25.2. Canada Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomic Biomarker Market

26.1. South America Genomic Biomarker Market Overview

26.2. South America Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomic Biomarker Market

27.1. Brazil Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomic Biomarker Market

28.1. Middle East Genomic Biomarker Market Overview

28.2. Middle East Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomic Biomarker Market

29.1. Africa Genomic Biomarker Market Overview

29.2. Africa Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomic Biomarker Market Competitive Landscape And Company Profiles

30.1. Genomic Biomarker Market Competitive Landscape

30.2. Genomic Biomarker Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Genomic Biomarker Market Other Major And Innovative Companies

31.1. Agilent Technologies Inc.

31.2. Illumina Inc.

31.3. PerkinElmer Inc.

31.4. Beckman Coulter Inc.

31.5. Bio-Rad Laboratories Inc.

31.6. Foundation Medicine Inc.

31.7. QIAGEN N.V.

31.8. Almac Group Ltd.

31.9. Myriad Genetics Inc.

31.10. Invitae Inc.

31.11. Guardant Health Inc.

31.12. Novogene Inc.

31.13. Twist Bioscience Corp.

31.14. NanoString Technologies Inc.

31.15. Quanterix Corp.

32. Global Genomic Biomarker Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomic Biomarker Market

34. Recent Developments In The Genomic Biomarker Market

35. Genomic Biomarker Market High Potential Countries, Segments and Strategies

35.1 Genomic Biomarker Market In 2029 - Countries Offering Most New Opportunities

35.2 Genomic Biomarker Market In 2029 - Segments Offering Most New Opportunities

35.3 Genomic Biomarker Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Genomic Biomarker Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Genomic Biomarker Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Genomic Biomarker Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Genomic Biomarker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Genomic Biomarker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Pfizer Inc. Financial Performance

Table 78: Roche Diagnostics Financial Performance

Table 79: Thermo Fisher Scientific Inc. Financial Performance

Table 80: Merck KGaA Financial Performance

Table 81: Eurofins Scientific SE Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Genomic Biomarker Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Genomic Biomarker Market, Sub-Segmentation Of Predictive Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Genomic Biomarker Market, Sub-Segmentation Of Prognostic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Genomic Biomarker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Genomic Biomarker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Genomic Biomarker Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Genomic Biomarker Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Genomic Biomarker Market, Segmentation By Validation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Pfizer Inc. Financial Performance

Figure 78: Roche Diagnostics Financial Performance

Figure 79: Thermo Fisher Scientific Inc. Financial Performance

Figure 80: Merck KGaA Financial Performance

Figure 81: Eurofins Scientific SE Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

Biomarkers Global Market Report 2025 – By Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), By Disease (Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases), By Type (Biomarker Of Exposure, Biomarker Of Diseases), By Audiences (Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies), By Application (Risk Assessment, Development of Molecular Diagnostic, Disease Diagnosis, Drug Discovery And Development, Drug Formulation, Forensic Application, Other Applications (DNA Fingerprinting And Others)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Renal Biomarkers Global Market Report 2025 – By Biomarker Type (Functional Biomarker, Up Regulated Protein, Other Biomarker Types), By Diagnostic Technique (Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)), By Application (Diagnosis And Disease Progression Monitoring, Research Homecare), By End User (Hospitals, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Biomarker Global Market Report 2025 – By Biomarkers Type (Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers), By Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Cytogenetics), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Thyroid Cancer, Kidney Cancer, Other Cancers), By Application (Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2025 – By Type (Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types), By Disease (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), By End Use (Research Institutes And Academics, Diagnostic Centers, Pharmaceutical Companies And Pharmaceutical Companies And Contract Research Organizations (CROs), Hospitals And Clinics, Other End-Uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Biomarkers Testing Global Market Report 2025 – By Biomarkers Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types), By Application (Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications), By End-User (Hospitals, Specialty Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Biomarkers Global Market Report 2025 – By Biomarkers Type (Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types), By Location Of Testing (Point Of Care Testing, Laboratory Testing), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications), By End User (Hospitals, Specialty Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Oncology Biomarkers Global Market Report 2025 – By Biomarker Type (Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers), By Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics, Other Profiling Technologies), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Leukemia, Ovarian Cancer, Liver Cancer, Other Cancer Types), By Application (Diagnostics, Research And Development, Prognostics, Risk Assessment, Other Applications), By End-User (Hospitals, Academic And Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Central Nervous System Biomarkers Global Market Report 2025 – By Type (Safety Biomarker, Efficacy Biomarker, Validation Biomarker, Other Types), By Disease (Multiple Sclerosis, Alzheimer's Disease, Parkinson's Disease, Traumatic Brain Injury, Other Diseases), By Application (Drug Discovery And Development, Personalized Medicines, Disease Risk Assessment, Diagnostics, Other Applications), By End-Users (Diagnostic Labs, Clinics, Hospitals, Research Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Genomic Biomarker market?

How will the Genomic Biomarker market drivers and restraints affect the market dynamics? What forces will shape the Genomic Biomarker industry going forward?

The Genomic Biomarker market major growth driver - Impact of Chronic Disease Prevalence on Genomic Biomarker Market Growth. For further insights on the Genomic Biomarker market, request a sample here

What is the forecast market size or the forecast market value of the Genomic Biomarker market?

The Genomic Biomarker market size has grown strongly in recent years. The genomic biomarker market size has grown rapidly in recent years. It will grow from $8.4 billion in 2024 to $9.9 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to growth in awareness of genetic disorders, rise in demand for targeted therapies, increasing utilization of big data in genomics, growth in global genomic databases, and rise in number of biomarker-based clinical trials. The genomic biomarker market size is expected to see rapid growth in the next few years. It will grow to $18.93 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to growing focus on the availability of personalized medications, rising occurrences of cardiovascular diseases, rising number of patients with neurological diseases, growing investments in genomic research, and growing adoption of personalized nutrition. Major trends in the forecast period include technological advancements, digital health, artificial intelligence, machine learning, and personalized medicine. For further insights on the Genomic Biomarker market, request a sample here

How is the Genomic Biomarker market segmented?

The genomic biomarker market covered in this report is segmented –
1) By Type: Predictive Biomarkers, Prognostic Biomarkers
2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications
3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility
4) By End-User: Hospitals, Diagnostic Centers, Research Laboratories, Other End Users Subsegments:
1) By Predictive Biomarkers: Genetic Biomarkers For Disease Susceptibility, Pharmacogenomic Biomarkers For Drug Response, Early Detection Biomarkers For Disease Prediction, Biomarkers For Treatment Response Prediction
2) By Prognostic Biomarkers: Biomarkers For Disease Progression, Biomarkers For Outcome Prediction, Survival And Recurrence Biomarkers, Biomarkers For Treatment Efficacy And Prognosis For further insights on the Genomic Biomarker market, request a sample here

Which region has the largest share of the Genomic Biomarker market? What are the other regions covered in the report?

Who are the major players in the Genomic Biomarker market?

What are the key trends in the Genomic Biomarker market?

Major trends in the Genomic Biomarker market include Technological Advances In Genomic Biomarkers. For further insights on the Genomic Biomarker market, request a sample here.

What are the major opportunities in the Genomic Biomarker market? What are the strategies for the Genomic Biomarker market?

For detailed insights on the major opportunities and strategies in the Genomic Biomarker market, request a sample here.

How does the Genomic Biomarker market relate to the overall economy and other similar markets?

For detailed insights on Genomic Biomarker's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Genomic Biomarker industry?

For detailed insights on the mergers and acquisitions in the Genomic Biomarker industry, request a sample here.

What are the key dynamics influencing the Genomic Biomarker market growth? SWOT analysis of the Genomic Biomarker market.

For detailed insights on the key dynamics influencing the Genomic Biomarker market growth and SWOT analysis of the Genomic Biomarker industry, request a sample here.